PedAM
Pediatric Disease Annotations & Medicines
| Disease | osteoporosis |
| Phenotype | C0020538|hypertension |
| Sentences | 10 |
| PubMedID- 24347992 | However, they have adverse effects: growth retardation in children, immunosuppression, hypertension, hyperglycemia, inhibition of wound repair, osteoporosis, metabolic disturbances, glaucoma, and cataracts. |
| PubMedID- 23675226 | Abdominal fat has been associated with insulin resistance (19), hyperlipidemia, hypertension (20), certain types of cancer (21) and osteoporosis (22). |
| PubMedID- 24926328 | To date, theories of metabolic disturbance, osteoporosis, intraosseous hypertension, intracellular coagulation and cytotoxicity have been hypothesized to explain its pathogenesis, but the underlying pathological change in onfh is microcirculation disturbance (1,2). |
| PubMedID- 23746264 | The most frequently reported comorbidities were hypertension (78·0% of patients), osteoporosis (22·8%), diabetes mellitus (33·9%), hypothyroidism (20·4%), hypercholesterolaemia (18·0%), hyperlipidaemia (16·7%) and depression (16·0%). |
| PubMedID- 22096630 | Chronic administration may even result in more serious side effects, such as hypertension, hyperglycemia, decline of cardiac conditions, osteoporosis and an increased incidence of fractures, hepatic steatosis, infection, cataract, and transient memory impairment [16]. |
| PubMedID- 23960439 | Because osteoporosis can coexist with hypertension, the choice of antihypertensive drugs could be influenced by their potential effect on bone and fracture risk, especially in postmenopausal women. |
| PubMedID- 22145134 | Some features such as increased intraocular pressure, cataracts, benign intracranial hypertension, aseptic necrosis of femoral head, osteoporosis, and pancreatitis are commoner in iatrogenic than in endogenous cs. |
| PubMedID- 26466937 | Efficacy and safety of risedronate in osteoporosis subjects with comorbid diabetes, hypertension, and/or dyslipidemia: a post hoc analysis of phase iii trials conducted in japan. |
| PubMedID- 22168267 | The exclusion criteria are: 1) known medical conditions or other physical problems that need special attention in an exercise program (e.g., history of myocardial infarction, angioplasty, or angina, admission to the hospital for evaluation of chest pain, use of nitroglycerin to treat angina, uncontrolled hypertension, diabetes mellitus with insulin treatment, osteoporosis, or under active treatment for cancer); 2) planning an international trip during the next four months (subjects are required to upload mobile phone data to a server daily, and will not be able to do so from abroad); 3) pregnant/delivered a baby during the past six months; 4) known severe hearing or speech problem; 5) history of eating disorder (e.g. |
| PubMedID- 23652773 | 23.3 %; p = 0.000), and there was a higher prevalence of hypertension among women with osteoporosis (32.2 vs. |
Page: 1